Zuellig expands cold chain

    258
    Well-equipped. Zuellig has ordered 10 additional ultra-low freezers on top of the 14 deployed through its network.

    Zuellig Pharma Corp. has increased its cold chain capacity in the Philippines for the new coronavirus disease 2019 vaccines it anticipates to receive, handle and distribute for manufacturers.

    Jannette Jakosalem, chief business officer of Zuellig Pharma in a statement said the company has ordered 10 additional ultra-low freezers on top of the 14 deployed through its network.

    This comes as the National Task Force assesses cold storage capacity in the country with the upcoming arrival of COVID-19 vaccines from various manufacturers.

    The company’s nationwide cold rooms, with temperatures of 2° to 8° Celsius, are located in Santa Rosa, Laguna; Sun Valley, Parañaque; Cebu and Davao, and can store up to 629 million vaccine doses. Its walk-in freezers can store up to 52 million doses at -15° to -25° Celsius.

    The company is also increasing its ultra-cold freezer capacity to 24 freezers that can store over seven million doses at temperatures as low as -70° to -80° Celsius, and can further ramp up this capacity if needed.

    The company’s cold chain capabilities include the eZCooler solution that extends the storage time of temperature-sensitive products in transit. Its COVID-19 digital care platform, eZVax, acts as a centralized hub coordinating and linking both stakeholders and processes through the whole mass vaccination program.